{"id":577,"date":"2022-07-13T12:51:44","date_gmt":"2022-07-13T12:51:44","guid":{"rendered":"https:\/\/sites.ncleg.gov\/ped\/?page_id=577"},"modified":"2022-07-26T17:10:27","modified_gmt":"2022-07-26T17:10:27","slug":"2017-06","status":"publish","type":"page","link":"https:\/\/sites.ncleg.gov\/ped\/2017-06\/","title":{"rendered":"Follow-up Report: Prescription Drug Monitoring (June 2017)"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large is-resized h-50 w-50 float-right pl-4 pt-2\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/sites.ncleg.gov\/ped\/wp-content\/uploads\/sites\/11\/2022\/07\/Rx_Photo-1.jpg\" alt=\"\" class=\"wp-image-581\" width=\"700\" height=\"600\"\/><\/figure>\n\n\n\n<p>This report documents legislative and agency actions undertaken in response to PED&#8217;s 2014 report,\u00a0<a href=\"https:\/\/sites.ncleg.gov\/ped\/2014-05\/\" target=\"_blank\" rel=\"noreferrer noopener\">North Carolina Needs to Strengthen Its System for Monitoring and Preventing the Abuse of Prescribed Controlled Substances<\/a>.<\/p>\n\n\n\n<p><a href=\"https:\/\/sites.ncleg.gov\/ped\/wp-content\/uploads\/sites\/11\/2022\/07\/Rx_Follow.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Follow-up Report<\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><br>Relevant Legislation:<\/h4>\n\n\n\n<ul class=\"wp-block-list\"><li><a href=\"https:\/\/sites.ncleg.gov\/ped\/wp-content\/uploads\/sites\/11\/2022\/07\/H97Section12F16.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Session Law 2015-241, Section 12F.16<\/a>&nbsp;requires adoption of statewide opioid prescribing guidelines and continuing education on the abuse of controlled substances for practitioners; directs the Department of Health and Human Services (DHHS) to improve Controlled Substances Reporting System (CSRS) access and utilization, improve the CSRS contract, and expand CSRS monitoring capacity; directs the Division of Medical Assistance (DMA) to improve the effectiveness and efficiency of the Medicaid lock-in program; and creates the Prescription Drug Abuse Advisory Committee and directs it to develop a statewide strategic plan and performance management system to combat prescription drug abuse.<\/li><li><a href=\"https:\/\/www.ncleg.gov\/BillLookUp\/2015\/S609\" target=\"_blank\" rel=\"noreferrer noopener\">Senate Bill 609<\/a>&nbsp;(2015\u201316): An act to require prescribers and dispensers to review information in the Controlled Substances Reporting System prior to prescribing or dispensing a controlled substance to a patient and to make a violation of that requirement a criminal offense.&nbsp;<strong>This legislation was not enacted<\/strong>.<\/li><\/ul>\n","protected":false},"excerpt":{"rendered":"<p>This report documents legislative and agency actions undertaken in response to PED&#8217;s 2014 report,\u00a0North Carolina Needs to Strengthen Its System for Monitoring and Preventing the Abuse of Prescribed Controlled Substances. Follow-up Report Relevant Legislation: Session Law 2015-241, Section 12F.16&nbsp;requires adoption of statewide opioid prescribing guidelines and continuing education on the abuse of controlled substances for [&hellip;]<\/p>\n","protected":false},"author":30,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_FSMCFIC_featured_image_caption":"","_FSMCFIC_featured_image_nocaption":"","_FSMCFIC_featured_image_hide":"","footnotes":""},"class_list":["post-577","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\r\n<title>Follow-up Report: Prescription Drug Monitoring (June 2017) - Program Evaluation Division<\/title>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/sites.ncleg.gov\/ped\/2017-06\/\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Follow-up Report: Prescription Drug Monitoring (June 2017) - Program Evaluation Division\" \/>\r\n<meta property=\"og:description\" content=\"This report documents legislative and agency actions undertaken in response to PED&#8217;s 2014 report,\u00a0North Carolina Needs to Strengthen Its System for Monitoring and Preventing the Abuse of Prescribed Controlled Substances. Follow-up Report Relevant Legislation: Session Law 2015-241, Section 12F.16&nbsp;requires adoption of statewide opioid prescribing guidelines and continuing education on the abuse of controlled substances for [&hellip;]\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/sites.ncleg.gov\/ped\/2017-06\/\" \/>\r\n<meta property=\"og:site_name\" content=\"Program Evaluation Division\" \/>\r\n<meta property=\"article:modified_time\" content=\"2022-07-26T17:10:27+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/sites.ncleg.gov\/ped\/wp-content\/uploads\/sites\/11\/2022\/07\/Rx_Photo-1.jpg\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/sites.ncleg.gov\/ped\/2017-06\/\",\"url\":\"https:\/\/sites.ncleg.gov\/ped\/2017-06\/\",\"name\":\"Follow-up Report: Prescription Drug Monitoring (June 2017) - Program Evaluation Division\",\"isPartOf\":{\"@id\":\"https:\/\/sites.ncleg.gov\/ped\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/sites.ncleg.gov\/ped\/2017-06\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/sites.ncleg.gov\/ped\/2017-06\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/sites.ncleg.gov\/ped\/wp-content\/uploads\/sites\/11\/2022\/07\/Rx_Photo-1.jpg\",\"datePublished\":\"2022-07-13T12:51:44+00:00\",\"dateModified\":\"2022-07-26T17:10:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/sites.ncleg.gov\/ped\/2017-06\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/sites.ncleg.gov\/ped\/2017-06\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sites.ncleg.gov\/ped\/2017-06\/#primaryimage\",\"url\":\"https:\/\/sites.ncleg.gov\/ped\/wp-content\/uploads\/sites\/11\/2022\/07\/Rx_Photo-1.jpg\",\"contentUrl\":\"https:\/\/sites.ncleg.gov\/ped\/wp-content\/uploads\/sites\/11\/2022\/07\/Rx_Photo-1.jpg\",\"width\":208,\"height\":208},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/sites.ncleg.gov\/ped\/2017-06\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/sites.ncleg.gov\/ped\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Follow-up Report: Prescription Drug Monitoring (June 2017)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/sites.ncleg.gov\/ped\/#website\",\"url\":\"https:\/\/sites.ncleg.gov\/ped\/\",\"name\":\"Program Evaluation Division\",\"description\":\"Just another NCGA Sites site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/sites.ncleg.gov\/ped\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Follow-up Report: Prescription Drug Monitoring (June 2017) - Program Evaluation Division","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sites.ncleg.gov\/ped\/2017-06\/","og_locale":"en_US","og_type":"article","og_title":"Follow-up Report: Prescription Drug Monitoring (June 2017) - Program Evaluation Division","og_description":"This report documents legislative and agency actions undertaken in response to PED&#8217;s 2014 report,\u00a0North Carolina Needs to Strengthen Its System for Monitoring and Preventing the Abuse of Prescribed Controlled Substances. Follow-up Report Relevant Legislation: Session Law 2015-241, Section 12F.16&nbsp;requires adoption of statewide opioid prescribing guidelines and continuing education on the abuse of controlled substances for [&hellip;]","og_url":"https:\/\/sites.ncleg.gov\/ped\/2017-06\/","og_site_name":"Program Evaluation Division","article_modified_time":"2022-07-26T17:10:27+00:00","og_image":[{"url":"https:\/\/sites.ncleg.gov\/ped\/wp-content\/uploads\/sites\/11\/2022\/07\/Rx_Photo-1.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/sites.ncleg.gov\/ped\/2017-06\/","url":"https:\/\/sites.ncleg.gov\/ped\/2017-06\/","name":"Follow-up Report: Prescription Drug Monitoring (June 2017) - Program Evaluation Division","isPartOf":{"@id":"https:\/\/sites.ncleg.gov\/ped\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sites.ncleg.gov\/ped\/2017-06\/#primaryimage"},"image":{"@id":"https:\/\/sites.ncleg.gov\/ped\/2017-06\/#primaryimage"},"thumbnailUrl":"https:\/\/sites.ncleg.gov\/ped\/wp-content\/uploads\/sites\/11\/2022\/07\/Rx_Photo-1.jpg","datePublished":"2022-07-13T12:51:44+00:00","dateModified":"2022-07-26T17:10:27+00:00","breadcrumb":{"@id":"https:\/\/sites.ncleg.gov\/ped\/2017-06\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sites.ncleg.gov\/ped\/2017-06\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sites.ncleg.gov\/ped\/2017-06\/#primaryimage","url":"https:\/\/sites.ncleg.gov\/ped\/wp-content\/uploads\/sites\/11\/2022\/07\/Rx_Photo-1.jpg","contentUrl":"https:\/\/sites.ncleg.gov\/ped\/wp-content\/uploads\/sites\/11\/2022\/07\/Rx_Photo-1.jpg","width":208,"height":208},{"@type":"BreadcrumbList","@id":"https:\/\/sites.ncleg.gov\/ped\/2017-06\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sites.ncleg.gov\/ped\/"},{"@type":"ListItem","position":2,"name":"Follow-up Report: Prescription Drug Monitoring (June 2017)"}]},{"@type":"WebSite","@id":"https:\/\/sites.ncleg.gov\/ped\/#website","url":"https:\/\/sites.ncleg.gov\/ped\/","name":"Program Evaluation Division","description":"Just another NCGA Sites site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sites.ncleg.gov\/ped\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/sites.ncleg.gov\/ped\/wp-json\/wp\/v2\/pages\/577","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.ncleg.gov\/ped\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.ncleg.gov\/ped\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.ncleg.gov\/ped\/wp-json\/wp\/v2\/users\/30"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.ncleg.gov\/ped\/wp-json\/wp\/v2\/comments?post=577"}],"version-history":[{"count":2,"href":"https:\/\/sites.ncleg.gov\/ped\/wp-json\/wp\/v2\/pages\/577\/revisions"}],"predecessor-version":[{"id":1538,"href":"https:\/\/sites.ncleg.gov\/ped\/wp-json\/wp\/v2\/pages\/577\/revisions\/1538"}],"wp:attachment":[{"href":"https:\/\/sites.ncleg.gov\/ped\/wp-json\/wp\/v2\/media?parent=577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}